BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pulitzer M. Cutaneous T-cell Lymphoma. Clin Lab Med 2017;37:527-46. [PMID: 28802499 DOI: 10.1016/j.cll.2017.06.006] [Cited by in Crossref: 28] [Cited by in F6Publishing: 19] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Cocks M, Porcu P, Wick MR, Gru AA. Recent Advances in Cutaneous T-cell Lymphoma. Surgical Pathology Clinics 2019;12:783-803. [DOI: 10.1016/j.path.2019.03.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
2 Wilhelm R, Eckes T, Imre G, Kippenberger S, Meissner M, Thomas D, Trautmann S, Merlio JP, Chevret E, Kaufmann R, Pfeilschifter J, Koch A, Jäger M. C6 Ceramide (d18:1/6:0) as a Novel Treatment of Cutaneous T Cell Lymphoma. Cancers (Basel) 2021;13:E270. [PMID: 33450826 DOI: 10.3390/cancers13020270] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Scarisbrick JJ, Bagot M, Ortiz-Romero PL. The changing therapeutic landscape, burden of disease, and unmet needs in patients with cutaneous T-cell lymphoma. Br J Haematol 2021;192:683-96. [PMID: 33095448 DOI: 10.1111/bjh.17117] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Pavlidis A, Piperi C, Papadavid E. Novel therapeutic approaches for cutaneous T cell lymphomas. Expert Rev Clin Immunol 2021;17:629-41. [PMID: 33890833 DOI: 10.1080/1744666X.2021.1919085] [Reference Citation Analysis]
5 Rindler K, Jonak C, Alkon N, Thaler FM, Kurz H, Shaw LE, Stingl G, Weninger W, Halbritter F, Bauer WM, Farlik M, Brunner PM. Single-cell RNA sequencing reveals markers of disease progression in primary cutaneous T-cell lymphoma. Mol Cancer 2021;20:124. [PMID: 34583709 DOI: 10.1186/s12943-021-01419-2] [Reference Citation Analysis]
6 Kamarádová K, Hrochová K, Salavec M, Belada D. T-cell receptor antibodies expression in benign and malignant cutaneous lymphoid infiltrates in comparison with T-cell receptor gene rearrangement and its diagnostic utility in borderline cases. Pathol Res Pract 2020;216:153279. [PMID: 33186884 DOI: 10.1016/j.prp.2020.153279] [Reference Citation Analysis]
7 Lee YP, Yoon SE, Song Y, Kim SJ, Yoon DH, Chen TY, Koh YI, Kang KW, Lee HS, Wei KTK, Lim ST, Poon M, Irawan C, Zhao W, Do YR, Lee MH, Ng SC, Lee WS, Guo Y, Zhang H, Kang HJ, Yun HJ, Kim HJ, Lung DTC, Kwak JY, Han JJ, Mun YC, Oh SY, Shim H, Kwon JH, Sohn BS, Park SK, Jo JC, Ko YH, Jun Z, Kim WS. Cutaneous T-cell lymphoma in Asian patients: a multinational, multicenter, prospective registry study in Asia. Int J Hematol 2021;114:355-62. [PMID: 34302593 DOI: 10.1007/s12185-021-03179-7] [Reference Citation Analysis]
8 Xiong C, Qi J, Deng R, Xie L, Li C, Nie X. [Total glucosides of paeony inhibits proliferation and promotes activation- induced cell death of mouse T cells in vitro]. Nan Fang Yi Ke Da Xue Xue Bao 2020;40:118-24. [PMID: 32376553 DOI: 10.12122/j.issn.1673-4254.2020.01.19] [Reference Citation Analysis]
9 Zohdy M, Abd El Hafez A, Abd Allah MYY, Bessar H, Refat S. Ki67 and CD31 Differential Expression in Cutaneous T-Cell Lymphoma and Its Mimickers: Association with Clinicopathological Criteria and Disease Advancement. Clin Cosmet Investig Dermatol 2020;13:431-42. [PMID: 32606882 DOI: 10.2147/CCID.S256269] [Reference Citation Analysis]
10 Sundram U. Cutaneous Lymphoproliferative Disorders: What's New in the Revised 4th Edition of the World Health Organization (WHO) Classification of Lymphoid Neoplasms. Adv Anat Pathol 2019;26:93-113. [PMID: 30199396 DOI: 10.1097/PAP.0000000000000208] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
11 Rajashekara Swamy M, Pollock S, J Goldberg L, Shen L. A case of lymphomatoid papulosis type E in a young adult: An uncommon entity. J Cutan Pathol 2021;48:694-700. [PMID: 33533041 DOI: 10.1111/cup.13974] [Reference Citation Analysis]
12 Hinkamp CA, Gupta S, Keshvani N. Severe adult-onset atopic dermatitis mistaken for cutaneous T-cell lymphoma in a medically complex patient. BMJ Case Rep 2020;13:e234445. [PMID: 32161083 DOI: 10.1136/bcr-2020-234445] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Choi J, Sutaria N, Roh YS, Bordeaux Z, Sweren RJ, Semenov YR, Kwatra SG. Racial and ethnic disparities in inpatient health care utilization for mycosis fungoides: A cross-sectional analysis of the 2012-2017 National Inpatient Sample. J Am Acad Dermatol 2021:S0190-9622(21)01106-3. [PMID: 34116099 DOI: 10.1016/j.jaad.2021.06.006] [Reference Citation Analysis]
14 Martínez Villarreal A, Gantchev J, Lagacé F, Barolet A, Sasseville D, Ødum N, Charli-Joseph YV, Hernández Salazar A, Litvinov IV. Hypopigmented Mycosis Fungoides: Loss of Pigmentation Reflects Antitumor Immune Response in Young Patients. Cancers (Basel) 2020;12:E2007. [PMID: 32707930 DOI: 10.3390/cancers12082007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Maitre E, Le‐page A, Comoz F, Truquet F, Damaj G, Cornet E, Verneuil L, Salaün V, Troussard X. Usefulness of Flow Cytometry for the Detection of Cutaneous Localization in Malignant Hematologic Disorders. Cytometry 2019;96:283-93. [DOI: 10.1002/cyto.b.21784] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
16 Martinez XU, Di Raimondo C, Abdulla FR, Zain J, Rosen ST, Querfeld C. Leukaemic variants of cutaneous T-cell lymphoma: Erythrodermic mycosis fungoides and Sézary syndrome. Best Pract Res Clin Haematol 2019;32:239-52. [PMID: 31585624 DOI: 10.1016/j.beha.2019.06.004] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Zhu L, Xie S, Yang C, Hua N, Wu Y, Wang L, Ni W, Tong X, Fei M, Wang S. Current Progress in Investigating Mature T- and NK-Cell Lymphoma Gene Aberrations by Next-Generation Sequencing (NGS). Cancer Manag Res 2021;13:5275-86. [PMID: 34239326 DOI: 10.2147/CMAR.S299505] [Reference Citation Analysis]
18 Gabes M. Are existing quality-of-life instruments in cutaneous T-cell lymphoma of sufficient quality? Br J Dermatol 2021;184:195. [PMID: 32869313 DOI: 10.1111/bjd.19408] [Reference Citation Analysis]
19 Yeşiltaş YS, Hoşal MB, Yüksel MK, Okçu Heper A. Severe upper eyelid mass in a patient with mycosis fungoides. Orbit 2020;39:150-2. [PMID: 31311383 DOI: 10.1080/01676830.2019.1639772] [Reference Citation Analysis]